Attention is paid to exclusion of genetic-metabolic liver disease in diagnosis of childhood drug-induced liver injury
10.3760/cma.j.cn101070-20200313-00394
- VernacularTitle:诊断儿童药物性肝损伤应重视除外遗传代谢性肝病
- Author:
Shishu ZHU
1
;
Yi DONG
Author Information
1. 解放军总医院第五医学中心青少年肝病中心，北京 100039
- From:
Chinese Journal of Applied Clinical Pediatrics
2020;35(9):653-655
- CountryChina
- Language:Chinese
-
Abstract:
Drug-induced liver injury (DILI) is a common disease in children with non-infectious liver di-seases, but there is no specific diagnostic method.Genetic-metabolic liver disease is a rare disease with low social recognition and requiring special examination to be diagnosed.The clinical manifestations of the 2 diseases are similar and complex, so it is easy to misdiagnose genetic-metabolic liver disease as DILI.In clinical practice, it is necessary to raise the awareness of excluding genetic-metabolic liver diseases in the diagnosis of DILI, so as to avoid misdiagnosis.
